Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online January 24, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0843v1
26/4/864    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Z.
Right arrow Articles by Wu, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Z.
Right arrow Articles by Wu, J. C.
Submitted on October 9, 2007
Accepted on January 16, 2008

EMBRYONIC STEM CELLS

Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects

Zongjin Li 1, Yoriyasu Suzuki 2, Mei Huang 1, Feng Cao 1, Xiaoyan Xie 1, Andrew J. Connolly 3, Phillip C. Yang 2, Joseph C. Wu 4*

1 Department of Radiology and Molecular Imaging Program at Stanford (MIPS), Stanford, CA, USA
2 Department of Medicine, Division of Cardiology, Stanford, CA, USA
3 Department of Pathology; Stanford University School of Medicine, Stanford, CA, USA
4 Department of Radiology and Molecular Imaging Program at Stanford (MIPS); Department of Medicine, Division of Cardiology, Stanford, CA, USA

* To whom correspondence should be addressed. E-mail: joewu{at}stanford.edu.


   Abstract

Human embryonic stem (hES) cells are pluripotent stem cells capable of self-renewal and differentiation into virtually all cell types. Thus, they hold tremendous potential as cell sources for regenerative therapies. The concurrent development of accurate, sensitive, and noninvasive technologies capable of monitoring hES cells engraftment in vivo can greatly expedite basic research prior to future clinical translation. In this study, hES cells were stably transduced with a lentiviral vector carrying a novel double-fusion reporter gene that consists of firefly luciferase and enhanced green fluorescence protein (Fluc-eGFP). Reporter gene expression had no adverse effects on cell viability, proliferation, or differentiation to endothelial cells (hESC-ECs). To compare the two popular imaging modalities, hES cells and hESC-ECs were then co-labeled with superparamagnetic iron oxide (SPIO) particles before transplantation into murine hindlimbs. Longitudinal magnetic resonance (MR) imaging showed persistent MR signals in both cell populations that lasted up to 4 weeks. By contrast, bioluminescence imaging indicated divergent signal patterns for hES cells and hESC-ECs. In particular, hESC-ECs showed significant bioluminescence signals at day 2, which decreased progressively over the following 4 weeks, whereas bioluminescence signals from undifferentiated hES cells increased dramatically during the same period. Postmortem histology and immunohistochemistry confirmed teratoma formation after injection of undifferentiated hES cells, but not hESC-ECs. Taken together, we conclude that reporter gene is a better marker for monitoring cell viability, whereas iron particle labeling is a better marker for high-resolution detection of cell location by MR. Furthermore, transplantation of pre-differentiated rather than undifferentiated hES cells would be more suited for avoiding teratoma formation.

Key Words. MRI, Bioluminescence Imaging, Human Embryonic Stem Cells, Endothelial Cells, Differentiation, Teratoma Formation, Acute Donor Cell Death




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
T.-C. Hung, Y. Suzuki, T. Urashima, A. Caffarelli, G. Hoyt, A. Y. Sheikh, A. C. Yeung, I. Weissman, R. C. Robbins, J. M. Bulte, et al.
Multimodality Evaluation of the Viability of Stem Cells Delivered Into Different Zones of Myocardial Infarction
Circ Cardiovasc Imaging, July 1, 2008; 1(1): 6 - 13.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2008 by AlphaMed Press.